India drug regulator asks Dr.Reddy’s for more data on Sputnik V COVID-19 vaccine

The committee asked the company to submit a comparative analysis of late-stage immunogenicity data from both its Indian studies and an ongoing Russian study, as well as data on serious adverse events and positive cases reported till date.